After-Hours Stock Movers:
FSD Pharma Inc. 11% LOWER; announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide ("PEA"), or FSD-201, for use in treating COVID-19.
BioLife Solutions Inc. 10.56% HIGHER; will replace Saia in the S&P SmallCap 600
Limoneira 10.7% LOWER; Prelim. Q3 Guidance Misses Consensus
Mimecast 7.12% HIGHER; will replace Cinemark Holdings Inc. (NYSE: CNK) in the S&P MidCap 400
Option Care Health Inc. 8% HIGHER; will replace Trustmark Corp. (NASDAQ: TRMK) in the S&P MidCap 400
Nordstrom 7.7% LOWER; reported Q2 EPS of $0.49, $0.21 better than the analyst estimate of $0.28. Revenue for the quarter came in at $3.66 billion versus the consensus estimate of $3.31 million. Revenue growth, including retail sales and credit card revenues of more than 35 percent.
Urban Outfitters (NASDAQ: URBN) 5.2% LOWER; reported Q2 EPS of $1.28, $0.50 better than the analyst estimate of $0.78. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.08 billion.
Intuit 1.8% HIGHER; reported Q4 EPS of $1.97, $0.29 better than the analyst estimate of $1.68. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.32 billion. Intuit sees FY2022 EPS of $11.05-$11.25, versus the consensus of $10.83. Intuit sees FY2022 revenue of $11.05-11.2 billion, versus the consensus of $10.94 billion. Intuit sees Q1 2022 EPS of $0.94-$0.99, versus the consensus of $1.14.
Bio-Techne 1% HIGHER; will replace Maxim Integrated Products Inc. (NASDAQ: MXIM) in the S&P 500